Cim Investment Management Inc V Tv Therapeutics Inc. Transaction History

Cim Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 02, 2022	SELL	$0.39 - $0.84 $61,976 - $133,488	-158,915 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.51 - $1.0 $9,413 - $18,458	-18,458 Reduced 10.41%	158,915 $115,000
Q4 2021 May 19, 2022	SELL	$0.95 - $1.69 $168,504 - $299,760	-177,373 Reduced 50.0%	177,373 $176,000
Q4 2021 Feb 02, 2022	BUY	$0.95 - $1.69 $168,504 - $299,760	177,373 Added 100.0%	354,746 $447,000
Q2 2021 Aug 13, 2021	BUY	$2.27 - $3.44 $126,128 - $191,136	55,563 Added 45.61%	177,373 $404,000

Q1 2021 May 20, 2021	BUY	$1.97 - $2.89 $239,965 - $352,030	121,810 New	121,810 $344,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.